Nuzenio

Tradingview Acadia Pharmaceuticals

Tradingview Acadia Pharmaceuticals entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 8 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Timeline

Wed, 05 Aug 2026 23:10:00 GMT3 Medical Stocks Standing Out After Crushing Q2 Earnings Expectations - TradingView
Wed, 05 Aug 2026 17:48:27 GMTACADIA Pharmaceuticals Inc. Revenue Breakdown – BMV:ACAD - TradingView
Wed, 05 Aug 2026 17:20:05 GMTACADIA Pharmaceuticals Inc. Stock 12‑Month Price Target Raised to $33.25, Implies 22% Upside - TradingView
Tue, 04 Aug 2026 22:51:36 GMTACAD: Q2 revenue rose 17% to $308M, led by DAYBUE STIX growth and raised 2026 guidance - TradingView
Tue, 04 Aug 2026 22:03:55 GMTACADIA Pharmaceuticals Q2 Earnings Call Highlights - TradingView
Tue, 04 Aug 2026 21:37:35 GMTACADIA Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary - TradingView

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Tradingview Acadia Pharmaceuticals.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.